Blair H. leads CannaWize’s editorial work across cannabis policy, patient access, scientific research, consumer labels, local guides, and product reporting.
Coverage Approach
Blair’s work begins with the document behind the claim: an agency page, rule, court order, study, laboratory report, or current product label. The goal is not to make cannabis sound harmless or frightening. It is to show readers what is known, what remains uncertain, and what must be verified before they act.
That approach is especially important in Texas, where medical cannabis, consumable hemp, local enforcement, and federal law operate through different systems. CannaWize distinguishes those systems instead of treating “legal cannabis” as one category.
Areas of Focus
- Texas medical-cannabis access and the Compassionate Use Registry.
- State and federal cannabis policy.
- Research interpretation and evidence quality.
- THC, CBD, minor cannabinoids, terpenes, and product labels.
- Independent reviews and certificates of analysis.
- Consumer safety, impairment, medication interactions, and myth checking.
Professional Boundaries
Blair is not presented by CannaWize as a physician, pharmacist, or attorney. Reporting explains public information and lived product context; it does not create a clinical or legal relationship. Individual decisions should be reviewed with a qualified professional when the stakes call for one.
Corrections and Contact
Readers can submit a source, factual correction, accessibility issue, or question through the contact form. Include the page address and the primary source that supports the requested change when possible.